OLYNTH 0.05% n runny nose dosing spray without conserv., 10 ml

Instructions for use for OLYNTH 0.05% n runny nose dosing spray without conserv., 10 ml

Detailed instructions for OLYNTH 0.05% n runny nose dosing spray without conserv., 10 ml

Field of use

• The preparation is a means for use in the nose (Rhinologikum) and contains the alpha sympathomimetics xylometazoline.
• Xylometazoline has vascular properties and thus causes a swelling of the mucous membrane.
• The medicine is used
  • to swell of the nasal mucosa (short -term treatment) in runny nose, seizure of flow sniffing (rhinitis vasomotorica) or allergic runny nose (rhinitis allergica)
  • to make the secretion outflow easier for inflammation of the sinuses and in the case of catarrh of the tube agent in connection with runny nose.
• The preparation is intended for children between 2 and 6 years.

Active ingredients / ingredients / ingredients

0.5 mg xylometazoline hydrochloride
0.44 mg xylometazoline
Dinatrium hydrogen phosphate 2-water auxiliary material (+)
Glycerol auxiliary substance (+)
Hyaluronic acid, sodium salt auxiliary material (+)
Sodium chloride auxiliary material (+)
Natrium dihydrogen phosphate 2-water auxiliary material (+)
Water, cleaned auxiliary material (+)

Contradictions

• The medicine must not be used
  • if you are hypersensitive (allergic) against xylometazoline or one of the other components of the preparation for children.
  • if you suffer from a certain form of chronic runny nose (rhinitis sicca, dry inflammation of the nasal mucosa with bark formation).
  • after surgical removal of the stone gland through the nose (transphenoidal hypophysectomy) or other surgical interventions that expose the meninges.
  • for infants and small children under 2 years.

dosage

• Always apply the medicine exactly according to the instruction. Please ask your doctor or pharmacist if you are not quite sure.
• Unless otherwise prescribed by the doctor, the usual dose is
  • In children between the ages of 2 and 6, however, 1 spray in each nasal opening is inserted up to 3 times a day.

• Duration of the application
  • The preparation must not be used for more than 7 days unless the medical order.
  • A new application should only take place after a break of several days.
  • Chronic runny nose may only be used due to the risk of the loss of the nasal mucosa.
  • Please speak to your doctor or pharmacist if you have the impression that the effect of the drug is too strong or too weak.

• If you have used a larger amount than you should
  • As a result of a significant overdose or by accidental taking the medicine, the following effects can occur:
    • Pupil extension or narrowing
    • Nausea and vomiting
    • Ballion, blue coloring of skin and lips
    • Fever, sweating or dropping the body temperature
    • Cardiovascular disorders such as too slower, too faster or irregular heartbeat, increase or drop in blood pressure
    • Exposition of the breathing
    • Lethargy, sleepiness and coma
    • Feeling of fear, excitement, hallucinations and cramps
  • Especially with Kinafter overdose, cramps and coma, slow heartbeat, exposure to breathing and an increase in blood pressure, which can be replaced by a drop in blood pressure.
  • In the event of poisoning, you must inform your doctor immediately, surveillance and therapy in the hospital are necessary.

• If you have forgotten the application
  • Next time, do not apply the double dose if you have forgotten the previous application, but continue the application as described in the dosage instructions.

• If you have any further questions about the application of the drug, ask your doctor or pharmacist.

Taking

• Insert the spray opening into the nostril and pump it once. Lightly inhale through the nose during the spray process.
• It is advisable to blow your nose thoroughly before using the preparation. The last application on every treatment day should be done cheaply before going to bed.
• For hygienic reasons and to avoid transmission of pathogens, each spray should only be used by one and the same person.

Patient information

• Particular caution when using the drug is required
  • if they are treated with certain mood-enhancing medicines (monoaminoxidase inhibitors [MAO-Hemmer]) and other potentially blood pressure-enhancing medicines.
  • if you suffer from increased intraocular pressure, especially narrow -angle glaucoma.
  • if you suffer from severe cardiovascular diseases (e.g. coronary heart disease [KHK], high blood pressure).
  • if you suffer from a tumor of the adrenal gland (Phäochromocytom).
  • if you have metabolic disorders such as B. hyperthyroidism or diabetes (diabetes mellitus) are available.
  • if you have an enlargement of prostate.
  • if you suffer porphyria from metabolic disease.
• The permanent use of sniffing-swelling sniffed medicines can lead to chronic swelling and finally to the loss of the nasal mucosa.
• Children
  • The preparation must not be used for infants and toddlers under 2 years.

• Wateriness and operating machines
  • No impairments can be expected in the event of intended use.

Pregnancy

• Since the security of the drug is not sufficiently proven during pregnancy and breastfeeding, you may only apply the preparation on the advice of your doctor and only after this has carried out careful benefits/risk assessment. During pregnancy and breastfeeding, the recommended dosage must not be exceeded, since overdose can affect blood supply to the unborn child or reduce milk production.

Hints

Miscellaneous

- The dosage depends on personal sensitivity and effect.
- In the case of longer use or higher amounts of the drug, effects with effects on the heart and vessels or central nervous effects cannot be ruled out. In these cases, the ability to carry a motor vehicle and to operate machines can be impaired.
- Longer or frequent use as well as higher amounts of the drug can lead to burning in the nose or dryness of the mucous membrane as well as a reactive swelling of the nasal mucosa with runny nose as a result (rhinitis medicamentosa). This effect can occur after 5-7-day treatment and, after continued application, cause permanent mucosal compensation with bark formation (rhinitis sicca).
- Especially with Lender use and overdose of punching of mucosal peeling can be increased blood flow to the nasal mucosa. This effect leads to a narrowing of the air routes, with the result that the medicine is used repeatedly up to permanent use. The result is chronic swellings (rhinitis medicamentosa) up to the shrinkage of the nasal mucosa (stinnnut).
- In lighter cases, it can be considered to only stop the medicine on a nostril and switch to the other side after the complaints have subsided in order to maintain at least part of the nasal breathing.
- The use of chronic runny nose may therefore only be carried out under medical control due to the risk of the loss of the nasal mucosa.

- For hygienic reasons and to avoid infections, it is pointed out that each dosing spray may only be used by one and the same person.